Rx DRUG PRICE ADVISORY COUNCIL MAY ALSO WEIGH REVIEW OF OTCs
This article was originally published in The Tan Sheet
Executive Summary
Rx DRUG PRICE ADVISORY COUNCIL MAY ALSO WEIGH REVIEW OF OTCs under legislation adopted by the House Education & Labor Committee June 15. The legislation, an amendment to President Clinton's Health Security Act (HR 3600) offered by Rep. George Miller (D- Calif.), would add the possibility of federal price reviews for OTC drugs to Clinton's health reform bill. The amendment was adopted by the panel in a 26-16 vote.